Literature DB >> 27466398

Diagnosis and Treatment of Congenital Chagas Disease in a Premature Infant.

Andrés Alarcón1,2, Mackenzie Morgan3, Susan P Montgomery4, Louis Scavo2,5,2, Edward C C Wong2,6,7, Andrea Hahn1,2,2, Barbara Jantausch1,2,2.   

Abstract

Entities:  

Keywords:  Trypanosoma cruzi; benznidazole; congenital Chagas disease

Mesh：

Substances：

Year:  2016        PMID： 27466398     DOI： 10.1093/jpids/piw043

Source DB:  PubMed          Journal:  J Pediatric Infect Dis Soc        ISSN： 2048-7193            Impact factor:   3.164


× No keyword cloud information.
  5 in total

Review 1.  Chagas Disease in the United States: a Public Health Approach.

Authors:  Caryn Bern; Louisa A Messenger; Jeffrey D Whitman; James H Maguire
Journal:  Clin Microbiol Rev       Date:  2019-11-27       Impact factor: 26.132

Review 2.  Oxidative stress implications for therapeutic vaccine development against Chagas disease.

Authors:  Subhadip Choudhuri; Lizette Rios; Juan Carlos Vázquez-Chagoyán; Nisha Jain Garg
Journal:  Expert Rev Vaccines       Date:  2021-08-30       Impact factor: 5.217

Review 3.  Updated Estimates and Mapping for Prevalence of Chagas Disease among Adults, United States.

Authors:  Amanda Irish; Jeffrey D Whitman; Eva H Clark; Rachel Marcus; Caryn Bern
Journal:  Emerg Infect Dis       Date:  2022-07       Impact factor: 16.126

Review 4.  Worldwide Control and Management of Chagas Disease in a New Era of Globalization: a Close Look at Congenital Trypanosoma cruzi Infection.

Authors:  Carmen Muñoz; Montserrat Gállego; Alba Abras; Cristina Ballart; Anna Fernández-Arévalo; María-Jesús Pinazo; Joaquim Gascón
Journal:  Clin Microbiol Rev       Date:  2022-03-03       Impact factor: 50.129

5.  Characteristics of Patients for Whom Benznidazole Was Released Through the CDC-Sponsored Investigational New Drug Program for Treatment of Chagas Disease - United States, 2011-2018.

Authors:  Barbara L Herwaldt; Cindy P Dougherty; Christopher K Allen; Julian P Jolly; Megan N Brown; Patricia Yu; Yon Yu
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2018-07-27       Impact factor: 17.586
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.